Paul Perreault
Chief Executive Officer at CSL Behring AB
Net worth: 31 M $ as of 2024-02-28
Profile
Currently, Paul Roger Perreault is Chief Executive Officer, Executive Director & MD at CSL Ltd. In his past career he held the position of Chairman-Global Board at Plasma Protein Therapeutics Association, Chief Executive Officer & Managing Director at CSL Behring LLC, Vice President & General Manager at Aventis Behring, Business Director at Wyeth-Ayerst Research and Vice President & General Manager at Aventis Bio-Services, Inc. Mr. Perreault received an undergraduate degree from the University of Central Florida.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
CSL LIMITED
0.03% | 2023-06-29 | 165,301 ( 0.03% ) | 31 M $ | 2024-02-28 |
Paul Perreault active positions
Companies | Position | Start |
---|---|---|
CSL Behring AB
CSL Behring AB Pharmaceuticals: MajorHealth Technology CSL Behring AB develops, manufactures, and markets protein-based therapies in the bleeding disorders, critical care, immunoglobulins, and pulmonary areas. It offers therapies such as plasma-derived and recombinant coagulation factors, immunoglobulins for the treatment of primary immune deficiency, alpha1-proteinase inhibitor for chronic A1-PI augmentation therapy, and C1-INH concentrate. The company was founded in 1904 and is headquartered in Danderyd, Sweden. | Chief Executive Officer | - |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Director/Board Member | 2020-11-30 |
CSL Finance Plc
CSL Finance Plc Finance/Rental/LeasingFinance Part of CSL Ltd., CSL Finance Plc provides finance services for group companies. The private company is based in Haywards Heath, UK. The British company was founded in 2002. The CEO is Paul Roger Perreault. | Chief Executive Officer | - |
Former positions of Paul Perreault
Companies | Position | End |
---|---|---|
CSL LIMITED | Chief Executive Officer | 2023-03-05 |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Chairman | - |
Aventis Behring | Corporate Officer/Principal | - |
Aventis Bio-Services, Inc.
Aventis Bio-Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Aventis Bio-Services, Inc. develops pharmaceutical and agricultural products. The private company is based in King of Prussia, PA. | Corporate Officer/Principal | - |
Wyeth-Ayerst Research | Corporate Officer/Principal | - |
Training of Paul Perreault
University of Central Florida | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CSL LIMITED | Health Technology |
Private companies | 8 |
---|---|
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Commercial Services |
Aventis Bio-Services, Inc.
Aventis Bio-Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Aventis Bio-Services, Inc. develops pharmaceutical and agricultural products. The private company is based in King of Prussia, PA. | Health Technology |
Aventis Behring | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
Wyeth-Ayerst Research | |
CSL Behring AB
CSL Behring AB Pharmaceuticals: MajorHealth Technology CSL Behring AB develops, manufactures, and markets protein-based therapies in the bleeding disorders, critical care, immunoglobulins, and pulmonary areas. It offers therapies such as plasma-derived and recombinant coagulation factors, immunoglobulins for the treatment of primary immune deficiency, alpha1-proteinase inhibitor for chronic A1-PI augmentation therapy, and C1-INH concentrate. The company was founded in 1904 and is headquartered in Danderyd, Sweden. | Health Technology |
CSL Finance Plc
CSL Finance Plc Finance/Rental/LeasingFinance Part of CSL Ltd., CSL Finance Plc provides finance services for group companies. The private company is based in Haywards Heath, UK. The British company was founded in 2002. The CEO is Paul Roger Perreault. | Finance |